An Ongoing Debate: Are the Patients Receiving Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin Receptor Blockers More Susceptible to COVID-19?

Date
2020
Author
Yılmaz, Sarper
Ertin, Hakan
Elaldı, Nazif
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/5554
https://doi.org/10.21673/anadoluklin.716125
Collections